[1]王露露.2019-2021年锦州乙型病毒性肝炎的流行病学特征[J].医学信息,2021,34(24):128-130.[doi:10.3969/j.issn.1006-1959.2021.24.032]
　WANG Lu-lu.Epidemiological Characteristics of Viral Hepatitis B in Jinzhou from 2019 to 2021[J].Medical Information,2021,34(24):128-130.[doi:10.3969/j.issn.1006-1959.2021.24.032]
点击复制

2019-2021年锦州乙型病毒性肝炎的流行病学特征()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年24期
页码:
128-130
栏目:
调查分析
出版日期:
2021-12-15

文章信息/Info

Title:
Epidemiological Characteristics of Viral Hepatitis B in Jinzhou from 2019 to 2021
文章编号:
1006-1959（2021）24-0128-03
作者:
王露露
（锦州市疾病预防控制中心消毒与病媒生物防制科，辽宁 锦州 121000）
Author(s):
WANG Lu-lu
(Department of Disinfection and Vector Biological Control,Jinzhou Center for Disease Control and Prevention,Jinzhou 121000,Liaoning,China)
关键词:
乙型病毒性肝炎; 流行病学特征; 肝硬化
Keywords:
Viral hepatitis B; Epidemiological characteristics; Liver cirrhosis
分类号:
R512.62；R181.3
DOI:
10.3969/j.issn.1006-1959.2021.24.032
文献标志码:
A
摘要:
目的 分析2019-2021年锦州乙型病毒性肝炎的流行病学特征，为科学防控提供一定的参考依据。方法 回顾分析2019-2021年我市120例乙型病毒性肝炎患者临床资料，应用描述性流行病学方法分析其流行病学特征。结果 2019年确诊乙型病毒性肝炎34例，死亡1例；2020年确诊乙型病毒性肝炎40例，死亡0例；2021年确诊乙型病毒性肝炎46例，死亡0例；全年各月均有乙肝病例发生，无明显发病高峰期，1月份发病率最高为12.50%。120例患者中男性乙型病毒性肝炎发生率高于女性（P＜0.05）；各年龄段均有病例发生，且多集中在20~65岁年龄段，占报告病例总数的89.16%；病例主要为农村、城镇、工业园区人员，占报告病例总数的98.83%；职业以农民、家务及待业人员、商业服务人员和工人最多。结论 锦州地区乙型病毒性肝炎发病率仍呈升高趋势，且男性发病率高于女性，以20~65岁人群为主，集中于农村、城镇、工业园区，多见于农民、家务及待业人员、商业服务人员和工人。应加强乙型病毒性肝炎防控工作，以降低乙型病毒性肝炎的发生率。
Abstract:
Objective To analyze the epidemiological characteristics of viral hepatitis B in Jinzhou from 2019 to 2021, and to provide reference for scientific prevention and control.Methods The clinical data of 120 patients with hepatitis B admitted to our hospital from 2019 to 2021 were retrospectively analyzed. Descriptive epidemiological method was used to analyze the epidemiological characteristics.Results In 2019, 34 cases of hepatitis B were diagnosed and 1 case died; in 2020, 40 cases of viral hepatitis B were diagnosed and 0 died; in 2021, 46 cases of viral hepatitis B were diagnosed and 0 died.Viral hepatitis B cases occurred every month throughout the year, no obvious peak incidence, the highest incidence of 12.50% in January. The incidence of hepatitis B in males was higher than that in females (P<0.05). Viral hepatitis B cases occurred in all age groups, and mostly concentrated in the 20-65 age group, accounting for 89.16% of the total number of reported cases; the cases were mainly rural, urban and industrial park personnel, accounting for 98.83% of the total reported cases; the most occupations were farmers, housework and unemployed, business service personnel and workers.Conclusion The incidence of viral hepatitis B in Jinzhou is still increasing, and the incidence of male is higher than that of female. The population aged 20-65 years old is mainly concentrated in rural areas, towns and industrial parks, and most of them are farmers, housework and unemployed personnel, business service personnel and workers. The prevention and control of hepatitis B should be strengthened to reduce the incidence of hepatitis B.

参考文献/References:

[1]彭江,董钧铭,姜明艳,等.安顺市2005-2014年乙型病毒性肝炎流行特征分析[J].医学动物防制,2016,32(5):491-493.[2]孙翔,刘元宝,许燕,等.2006-2015年江苏省急性乙型病毒性肝炎发病率趋势分析[J].现代预防医学,2017,44(12):2279-2282.[3]曾藓惠,谢志春.我国乙肝疫苗接种预防成就及面临的挑战[J].应用预防医学,2018,24(6):496-498.[4]张国民,缪宁,郑徽,等.中国2005-2016年乙型病毒性肝炎报告发病的年龄和地区特征[J].中国疫苗和免疫,2018,24(2):121-126.[5]Cui F,Shen L,Li L,et al.Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China[J].Emerg Infect Dis,2017,23(5):765-772.[6]朱立国,姜洁,宋词,等.江苏省2012-2014年HBV携带者进展为慢性乙型肝炎患者的队列特征分析[J].中华流行病学杂志,2016,37(11):1463-1467.[7]Liu J,Liang W,Jing W,et al.Countdown to 2030: eliminating hepatitis B disease, China[J].Bull World Health Organ,2019,97(3):230-238.[8]陈霞,王玉平.HBsAg阳性母亲新生儿乙肝疫苗应答的影响因素研究[J].中国妇幼健康研究,2018,29(8):958-961.[9]王雪飞,史晓红,许喜喜,等.白介素-6和白介素-12在HBsAg阳性母亲婴儿乙肝疫苗免疫应答中的作用[J].中华流行病学杂志,2017,38(7):950-953.[10]杨志清,郝海昀,史晓红,等.HBsAg阳性母亲HBV感染状况与婴儿乙肝疫苗无/弱应答的关系[J].中华流行病学杂志,2018,39(6):805-809.[11]曾滢,陈鲁粤,杨忠华,等.16岁及以上人群接种60 μg重组乙肝疫苗安全性及免疫原性研究[J].预防医学,2017,29(9):869-873.[12]林春蕾,王岩,李涛,等.接受抗病毒治疗的代偿期乙肝肝硬化患者进展为肝癌的危险因素分析[J].山东医药,2017,57(32):81.[13]杨兆利,白红英.乙型肝炎病毒流行地区他汀类药物诱发肝损伤的危险因素分析[J].广东医学,2018,39(7):1040.[14]王祖煜,刘熠赫,张芮,等.2004-2013年中国乙型病毒性肝炎的流行病学特征研究[J].中国全科医学,2017,20(23):2879-2881.[15]Abu-Amara M,Cerocchi O,Malhi G,et al.The applicabil- ity of hepatocellular carcinoma risk prediction scores in a North A- merican patient population with chronic hepatitis B infection[J].Gut,2016(65):1347-1358.[16]李桂霞,陈富明,彭武建,等.抗乙肝病毒药物对慢性乙型病毒性肝炎患者肾功能的影响及其危险因素分析[J].解放军预防医学杂志,2019,37(8):14-16.[17]Tong S,Revill P.Overview of hepatitis B viral replication and genetic variability[J].J Hepatol,2016,64(1 Suppl):S4-S16.[18]项东,张利焱,王良群,等.2010-2014年唐山市病毒性肝炎流行特征及防控对策分析[J].医学动物防制,2016,32(8):911-913.[19]阿克忠,郝增平,马小军,等.青海省乙型病毒性肝炎报告发病质量评价[J].医学动物防制,2018,34(4):328-331.[20]唐丽,胡锦流.2006-2015年江苏淮安市乙型病毒性肝炎流行病学分析[J].现代预防医学,2017,44(11):1929-1931.

相似文献/References:

[1]邬 剑,李慧玲.ELISA法和胶体金试纸条法在乙肝表面抗原 检测中的应用研究[J].医学信息,2018,31(09):155.[doi:10.3969/j.issn.1006-1959.2018.09.050]
　WU Jian,LI Hui-ling.Application of ELISA and Colloidal Gold Strip in the Detection of Hepatitis B Surface Antigen[J].Medical Information,2018,31(24):155.[doi:10.3969/j.issn.1006-1959.2018.09.050]
[2]姜巧巧,李利伟,郭 政.某综合医院84例麻疹患者流行病学资料分析[J].医学信息,2018,31(10):122.[doi:10.3969/j.issn.1006-1959.2018.10.039]
　JIANG Qiao-qiao,LI Li-wei,GUO Zheng.Analysis of Epidemiological Data of 84 Measles Patients in a General Hospital[J].Medical Information,2018,31(24):122.[doi:10.3969/j.issn.1006-1959.2018.10.039]
[3]陈倩如.大肠癌住院病例临床特征分析[J].医学信息,2019,32(02):145.[doi:10.3969/j.issn.1006-1959.2019.02.042]
　CHEN Qian-ru.Analysis of Clinical Features of Hospitalized Cases of Colorectal Cancer[J].Medical Information,2019,32(24):145.[doi:10.3969/j.issn.1006-1959.2019.02.042]
[4]朱 珠,吴明洋,王星新.2007~2016年四川省攀枝花市仁和区流行性腮腺炎流行病学特征分析[J].医学信息,2018,31(23):126.[doi:10.3969/j.issn.1006-1959.2018.23.035]
　ZHU Zhu,WU Ming-yang,WANG Xing-xin.Epidemiological Characteristics of Epidemic Parotiditis in Renhe District,Panzhihua City,Sichuan Province from 2007 to 2016[J].Medical Information,2018,31(24):126.[doi:10.3969/j.issn.1006-1959.2018.23.035]
[5]马 琳,田瑞民.乙型病毒性肝炎相关晚期肝病的抗病毒治疗效果观察[J].医学信息,2019,32(07):120.[doi:10.3969/j.issn.1006-1959.2019.07.036]
　MA Lin,TIAN Rui-min.Observation on the Effect of Antiviral Therapy For Advanced Hepatopathy Associated with Viral Hepatitis B[J].Medical Information,2019,32(24):120.[doi:10.3969/j.issn.1006-1959.2019.07.036]
[6]李华伟,黄学武.青年肺癌与老年肺癌的研究现状[J].医学信息,2019,32(19):54.[doi:10.3969/j.issn.1006-1959.2019.19.017]
　LI Hua-wei,HUANG Xue-wu.Current Status of Research on Young Lung Cancer and Elderly Lung Cancer[J].Medical Information,2019,32(24):54.[doi:10.3969/j.issn.1006-1959.2019.19.017]
[7]钱 云.南通市某传染病医院艾滋病流行病学特征分析[J].医学信息,2019,32(24):130.[doi:10.3969/j.issn.1006-1959.2019.24.046]
　QIAN Yun.Epidemiological Characteristics of AIDS in an Infectious Disease Hospital in Nantong[J].Medical Information,2019,32(24):130.[doi:10.3969/j.issn.1006-1959.2019.24.046]
[8]张 赓.自身抗体在自身免疫性肝炎和乙型病毒性肝炎中的特征分析[J].医学信息,2020,33(05):173.[doi:10.3969/j.issn.1006-1959.2020.05.059]
　ZHANG Geng.Analysis of the Characteristics of Autoantibodies in Autoimmune Hepatitis and Viral Hepatitis B[J].Medical Information,2020,33(24):173.[doi:10.3969/j.issn.1006-1959.2020.05.059]
[9]宋 丹,韩亚凤.2010~2019年天津市河北区乙型病毒性肝炎流行病学分析[J].医学信息,2020,33(16):125.[doi:10.3969/j.issn.1006-1959.2020.16.039]
　SONG Dan,HAN Ya-feng.Epidemiological Analysis of Viral Hepatitis B in Hebei District of Tianjin from 2010 to 2019[J].Medical Information,2020,33(24):125.[doi:10.3969/j.issn.1006-1959.2020.16.039]
[10]刘 芳,季 良,姜海燕,等.肝爽颗粒联合富马酸替诺福韦二吡呋酯片对乙型病毒性肝炎肝硬化患者APRI、FIB-4的影响[J].医学信息,2021,34(05):104.[doi:10.3969/j.issn.1006-1959.2021.05.029]
　LIU Fang,JI Liang,JIANG Hai-yan,et al.The Effect of Ganshuang Granule Combined with Tenofovir Disoproxil Fumarate Tablets on APRI and FIB-4 in Patients with Hepatitis B Liver Cirrhosis[J].Medical Information,2021,34(24):104.[doi:10.3969/j.issn.1006-1959.2021.05.029]

更新日期/Last Update: 1900-01-01